PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23219579-0	2013	Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats.	Dexmedetomidine	67-82	mitogen activated protein kinase 3	Rattus norvegicus	18-24	
23219579-10	2013	The increasing expressions of p-Akt and p-ERK1/2 induced by Dex in the ischemic hemisphere were markedly inhibited by LY294002 (or wortmannin) and U0126 (or PD98059), respectively.	Dexmedetomidine	60-63	mitogen activated protein kinase 3	Rattus norvegicus	42-48	
23219579-12	2013	Our data demonstrated that treatment with Dex reduced cerebral injury in rats exposed to transient focal I/R, and this was mediated by the activation of the PI3K/Akt and ERK1/2 pathways as well the phosphorylation of downstream GSK-3beta.	Dexmedetomidine	42-45	mitogen activated protein kinase 3	Rattus norvegicus	170-176